| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
20,762 |
19,003 |
$1.28M |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
6,972 |
6,819 |
$132K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,853 |
2,431 |
$129K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,311 |
1,301 |
$110K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
1,101 |
1,094 |
$97K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
9,330 |
9,228 |
$95K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
896 |
893 |
$79K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
880 |
858 |
$78K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
589 |
586 |
$57K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
2,644 |
2,600 |
$44K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
327 |
293 |
$25K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
630 |
517 |
$16K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
447 |
390 |
$14K |
| 81002 |
|
3,586 |
3,527 |
$10K |
| 87430 |
|
699 |
602 |
$9K |
| 87634 |
|
136 |
120 |
$8K |
| 85018 |
|
2,776 |
2,752 |
$6K |
| 84203 |
|
688 |
683 |
$6K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
602 |
443 |
$5K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
483 |
352 |
$4K |
| 94760 |
|
1,602 |
1,492 |
$3K |
| 99177 |
|
734 |
730 |
$3K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
51 |
51 |
$2K |
| 92587 |
|
153 |
122 |
$2K |
| S0302 |
Completed early periodic screening diagnosis and treatment (epsdt) service (list in addition to code for appropriate evaluation and management service) |
242 |
242 |
$2K |
| 96127 |
|
251 |
217 |
$2K |
| 88738 |
|
972 |
970 |
$1K |
| 87400 |
|
114 |
96 |
$1K |
| 87420 |
|
14 |
14 |
$171.78 |
| 87807 |
|
15 |
14 |
$153.16 |
| 96161 |
|
75 |
72 |
$151.94 |
| 90686 |
|
1,605 |
1,585 |
$123.67 |
| 90677 |
|
214 |
211 |
$0.01 |
| 90680 |
|
158 |
155 |
$0.00 |
| 90697 |
|
95 |
92 |
$0.00 |
| 90698 |
|
85 |
85 |
$0.00 |
| 91307 |
|
38 |
31 |
$0.00 |
| 99072 |
|
1,158 |
1,091 |
$0.00 |
| G2211 |
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) |
556 |
532 |
$0.00 |
| 90670 |
|
85 |
85 |
$0.00 |
| 90633 |
|
28 |
27 |
$0.00 |